Epigenetics of alcohol-related liver diseases

[1]  G. Szabo,et al.  Extracellular vesicles in inflammation: Focus on the microRNA cargo of EVs in modulation of liver diseases , 2021, Journal of leukocyte biology.

[2]  F. Foufelle,et al.  SREBP-1c and lipogenesis in the liver: an update1. , 2021, The Biochemical journal.

[3]  Lin Zhang,et al.  SIRT2-mediated deacetylation and deubiquitination of C/EBPβ prevents ethanol-induced liver injury , 2021, Cell Discovery.

[4]  S. Pfister,et al.  Developmental and evolutionary dynamics of cis-regulatory elements in mouse cerebellar cells , 2021, Science.

[5]  Judith B. Zaugg,et al.  Enhancers in disease: molecular basis and emerging treatment strategies. , 2021, Trends in molecular medicine.

[6]  M. Skrzypczak,et al.  Epigenetic Changes Affecting the Development of Hepatocellular Carcinoma , 2021, Cancers.

[7]  Songtao Li,et al.  Comprehensive Analysis of the Expression Profiles of Hepatic lncRNAs in the Mouse Model of Alcoholic Liver Disease , 2021, Frontiers in Pharmacology.

[8]  Tomoko Tadokoro,et al.  Diagnosis and Therapeutic Management of Liver Fibrosis by MicroRNA , 2021, International journal of molecular sciences.

[9]  R. Bataller,et al.  Super enhancer regulation of cytokine-induced chemokine production in alcoholic hepatitis , 2021, Nature Communications.

[10]  Jeongkyu Kim,et al.  The Role of Epigenetic Changes in the Progression of Alcoholic Steatohepatitis , 2021, Frontiers in Physiology.

[11]  Y. Kanki,et al.  Potential roles of super enhancers in inflammatory gene transcription , 2021, The FEBS journal.

[12]  V. Shah,et al.  Regulation and functional roles of chemokines in liver diseases , 2021, Nature Reviews Gastroenterology & Hepatology.

[13]  G. Gores,et al.  XIAP Knockdown in Alcohol-Associated Liver Disease Models Exhibits Divergent in vitro and in vivo Phenotypes Owing to a Potential Zonal Inhibitory Role of SMAC , 2021, Frontiers in Physiology.

[14]  I. Tsai,et al.  Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives , 2021, International journal of molecular sciences.

[15]  Kunming Zhao,et al.  A novel epigenetic mechanism unravels hsa-miR-148a-3p-mediated CYP2B6 downregulation in alcoholic hepatitis disease. , 2021, Biochemical pharmacology.

[16]  W. Foulkes,et al.  Achieving clinical success with BET inhibitors as anti-cancer agents , 2021, British Journal of Cancer.

[17]  A. Dent,et al.  Stress‐Responsive Gene FK506‐Binding Protein 51 Mediates Alcohol‐Induced Liver Injury Through the Hippo Pathway and Chemokine (C‐X‐C Motif) Ligand 1 Signaling , 2021, Hepatology.

[18]  M. Ávila,et al.  Epigenetic Biomarkers for the Diagnosis and Treatment of Liver Disease , 2021, Cancers.

[19]  L. Nagy,et al.  Gene Deconvolution Reveals Aberrant Liver Regeneration and Immune Cell Infiltration in Alcohol‐Associated Hepatitis , 2021, Hepatology.

[20]  Dianke Yu,et al.  A novel mechanism underlying alcohol dehydrogenase expression: hsa-miR-148a-3p promotes ADH4 expression via an AGO1-dependent manner in control and ethanol-exposed hepatic cells. , 2021, Biochemical pharmacology.

[21]  A. Duseja,et al.  Genetic and epigenetic disease modifiers: non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD). , 2021, Translational gastroenterology and hepatology.

[22]  K. Bachman,et al.  Integration of the Transcriptome and Genome-Wide Landscape of BRD2 and BRD4 Binding Motifs Identifies Key Superenhancer Genes and Reveals the Mechanism of Bet Inhibitor Action in Rheumatoid Arthritis Synovial Fibroblasts , 2020, The Journal of Immunology.

[23]  S. Gregory,et al.  Single-cell omics analysis reveals functional diversification of hepatocytes during liver regeneration , 2020, JCI insight.

[24]  P. Vidigal,et al.  Neutrophils interact with cholangiocytes to cause cholestatic changes in alcoholic hepatitis , 2020, Gut.

[25]  V. Shah,et al.  Endothelial p300 Promotes Portal Hypertension and Hepatic Fibrosis Through C‐C Motif Chemokine Ligand 2–Mediated Angiocrine Signaling , 2020, Hepatology.

[26]  R. Xu,et al.  Neutrophils in liver diseases: pathogenesis and therapeutic targets , 2020, Cellular & Molecular Immunology.

[27]  D. Brenner,et al.  Molecular and cellular mechanisms of liver fibrosis and its regression , 2020, Nature Reviews Gastroenterology & Hepatology.

[28]  Xiaolin Wang,et al.  MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases , 2020, Gut.

[29]  D. Broszczak,et al.  The use of minimally invasive biomarkers for the diagnosis and prognosis of hepatocellular carcinoma. , 2020, Biochimica et biophysica acta. Reviews on cancer.

[30]  L. Kaderali,et al.  Identifying Differentially Expressed MicroRNAs, Target Genes, and Key Pathways Deregulated in Patients with Liver Diseases , 2020, International journal of molecular sciences.

[31]  S. Goerdt,et al.  Endothelial GATA4 controls liver fibrosis and regeneration by preventing a pathogenic switch in angiocrine signaling. , 2020, Journal of hepatology.

[32]  M. Ávila,et al.  Epigenetics in hepatocellular carcinoma development and therapy: The tip of the iceberg , 2020, JHEP reports : innovation in hepatology.

[33]  Xiao-ming Meng,et al.  MicroRNA-708 prevents ethanol-induced hepatic lipid accumulation and inflammatory reaction via direct targeting ZEB1. , 2020, Life sciences.

[34]  Ruiwen Wang,et al.  Salvianic acid A alleviates chronic alcoholic liver disease by inhibiting HMGB1 translocation via down‐regulating BRD4 , 2020, Journal of cellular and molecular medicine.

[35]  V. Gnemmi,et al.  Combined alcoholic and non-alcoholic steatohepatitis , 2020, JHEP reports : innovation in hepatology.

[36]  C. Datz,et al.  Genetic Variation in HSD17B13 Reduces the Risk of Developing Cirrhosis and Hepatocellular Carcinoma in Alcohol Misusers , 2020, Hepatology.

[37]  H. Barrera-Saldana,et al.  Liquid biopsy in chronic liver disease. , 2020, Annals of hepatology.

[38]  F. Prósper,et al.  Epigenetic mechanisms and metabolic reprogramming in fibrogenesis: dual targeting of G9a and DNMT1 for the inhibition of liver fibrosis , 2020, Gut.

[39]  P. Grandi,et al.  Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation , 2020, Science.

[40]  K. Natarajan,et al.  Transcriptional Dynamics of Hepatic Sinusoid‐Associated Cells After Liver Injury , 2020, Hepatology.

[41]  Jishnu Das,et al.  Epigenetic basis for monocyte dysfunction in patients with severe alcoholic hepatitis. , 2020, Journal of hepatology.

[42]  Sara A. Grimm,et al.  Alterations in promoter interaction landscape and transcriptional network underlying metabolic adaptation to diet , 2020, Nature Communications.

[43]  Douglas A. Simonetto,et al.  Hepatic stellate cell activation promotes alcohol-induced steatohepatitis through Igfbp3 and SerpinA12. , 2020, Journal of hepatology.

[44]  R. Loomba,et al.  Advances in non-invasive assessment of hepatic fibrosis , 2020, Gut.

[45]  Faqing Tang,et al.  Super-enhancer function and its application in cancer targeted therapy , 2020, npj Precision Oncology.

[46]  K. Ressler,et al.  The glucocorticoid receptor-FKBP51 complex contributes to fear conditioning and posttraumatic stress disorder. , 2020, The Journal of clinical investigation.

[47]  D. Crabb,et al.  Diagnosis and Treatment of Alcohol‐Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases , 2020, Hepatology.

[48]  M. Primig,et al.  Transgenerational Inheritance of Environmentally Induced Epigenetic Alterations during Mammalian Development , 2019, Cells.

[49]  M. Rots,et al.  The timeline of epigenetic drug discovery: from reality to dreams , 2019, Clinical Epigenetics.

[50]  Junhong Han,et al.  Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials , 2019, Signal Transduction and Targeted Therapy.

[51]  J. Mann,et al.  Fibrogenic Activity of MECP2 Is Regulated by Phosphorylation in Hepatic Stellate Cells , 2019, Gastroenterology.

[52]  P. Lorkiewicz,et al.  Tributyrin Inhibits Ethanol-Induced Epigenetic Repression of CPT-1A and Attenuates Hepatic Steatosis and Injury , 2019, Cellular and molecular gastroenterology and hepatology.

[53]  Derek J Van Booven,et al.  Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis , 2019, Nature Communications.

[54]  T. Aune,et al.  Bromodomain inhibitor JQ1 reversibly blocks IFN-γ production , 2019, Scientific Reports.

[55]  B. Attar,et al.  Safety and Efficacy of Infliximab in Severe Alcoholic Hepatitis: A Systematic Review , 2019, Cureus.

[56]  E. Heard,et al.  Advances in epigenetics link genetics to the environment and disease , 2019, Nature.

[57]  Jhin Jieh Lim,et al.  Epigenetics of hepatocellular carcinoma , 2019, Clinical and Translational Medicine.

[58]  M. Ziol,et al.  A 17‐Beta‐Hydroxysteroid Dehydrogenase 13 Variant Protects From Hepatocellular Carcinoma Development in Alcoholic Liver Disease , 2019, Hepatology.

[59]  K. Grant,et al.  Chronic heavy drinking drives distinct transcriptional and epigenetic changes in splenic macrophages , 2019, EBioMedicine.

[60]  B. Peters,et al.  An ATAC-seq atlas of chromatin accessibility in mouse tissues , 2019, Scientific Data.

[61]  H. Tsukamoto,et al.  Inflammatory pathways in alcoholic steatohepatitis. , 2019, Journal of hepatology.

[62]  A. Farcomeni,et al.  A two gene-based risk score predicts alcoholic cirrhosis development in males with at-risk alcohol consumption , 2019, The application of clinical genetics.

[63]  Kevin C. Wang,et al.  Immune genes are primed for robust transcription by proximal long noncoding RNAs located in nuclear compartments , 2018, Nature Genetics.

[64]  H. Aburatani,et al.  Coordinated demethylation of H3K9 and H3K27 is required for rapid inflammatory responses of endothelial cells , 2018, bioRxiv.

[65]  Manel Esteller,et al.  Clinical epigenetics: seizing opportunities for translation , 2018, Nature Reviews Genetics.

[66]  Cheng Huang,et al.  Suppression of SUN2 by DNA methylation is associated with HSCs activation and hepatic fibrosis , 2018, Cell Death & Disease.

[67]  S. Biswas,et al.  Epigenetic tools (The Writers, The Readers and The Erasers) and their implications in cancer therapy. , 2018, European journal of pharmacology.

[68]  M. Marcos,et al.  Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease , 2018, World journal of gastroenterology.

[69]  N. Mishra,et al.  Molecular Basis for the N-Terminal Bromodomain-and-Extra-Terminal-Family Selectivity of a Dual Kinase-Bromodomain Inhibitor. , 2018, Journal of medicinal chemistry.

[70]  H. Reeves,et al.  Liquid biopsy for liver diseases , 2018, Gut.

[71]  Wei Zhang,et al.  Reversing Epigenetic Alterations Caused by Alcohol: A Promising Therapeutic Direction for Alcoholic Liver Disease. , 2018, Alcoholism, clinical and experimental research.

[72]  B. Horsthemke.  A critical view on transgenerational epigenetic inheritance in humans , 2018, Nature Communications.

[73]  Sandy L. Klemm,et al.  High-throughput chromatin accessibility profiling at single-cell resolution , 2018, Nature Communications.

[74]  Ayush T. Raman,et al.  An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues. , 2018, Journal of visualized experiments : JoVE.

[75]  Alexander E. Lopez,et al.  A Protein‐Truncating HSD17B13 Variant and Protection from Chronic Liver Disease , 2018, The New England journal of medicine.

[76]  F. Lammert,et al.  Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol‐related cirrhosis , 2018, The American Journal of Gastroenterology.

[77]  Shari S. Rogal,et al.  Post-transplant Outcomes of Persons Receiving a Liver Graft for Alcoholic Liver Disease , 2018, Alcohol and alcoholism.

[78]  M. Volk,et al.  Transplantation for Alcohol-related Liver Disease: Is It Fair? , 2018, Alcohol and alcoholism.

[79]  Tae Hyun Kim,et al.  Alcohol dysregulates miR-148a in hepatocytes through FoxO1, facilitating pyroptosis via TXNIP overexpression , 2018, Gut.

[80]  J. Mann,et al.  Plasma cell-free DNA methylation: a liquid biomarker of hepatic fibrosis , 2018, Gut.

[81]  S. Glaser,et al.  Regulation of Cellular Senescence by miR-34a in Alcoholic Liver Injury. , 2017, The American journal of pathology.

[82]  P. Kharchenko,et al.  Integrative single-cell analysis of transcriptional and epigenetic states in the human adult brain , 2017, Nature Biotechnology.

[83]  C. A. de la Motte,et al.  Hyaluronic acid 35 normalizes TLR4 signaling in Kupffer cells from ethanol-fed rats via regulation of microRNA291b and its target Tollip , 2017, Scientific Reports.

[84]  Li Yang,et al.  A single‐cell transcriptomic analysis reveals precise pathways and regulatory mechanisms underlying hepatoblast differentiation , 2017, Hepatology.

[85]  G. Gores,et al.  Therapeutic opportunities for alcoholic steatohepatitis and nonalcoholic steatohepatitis: exploiting similarities and differences in pathogenesis. , 2017, JCI insight.

[86]  K. Kodys,et al.  Alcohol‐induced miR‐155 and HDAC11 inhibit negative regulators of the TLR4 pathway and lead to increased LPS responsiveness of Kupffer cells in alcoholic liver disease , 2017, Journal of leukocyte biology.

[87]  C. A. de la Motte,et al.  MicroRNA 181b‐3p and its target importin α5 regulate toll‐like receptor 4 signaling in Kupffer cells and liver injury in mice in response to ethanol , 2017, Hepatology.

[88]  W. Tu,et al.  LncRNA AK054921 and AK128652 are potential serum biomarkers and predictors of patient survival with alcoholic cirrhosis , 2017, Hepatology communications.

[89]  R. Bataller,et al.  A prospective study of the utility of plasma biomarkers to diagnose alcoholic hepatitis , 2017, Hepatology.

[90]  G. Szabo,et al.  Gut–liver axis and sterile signals in the development of alcoholic liver disease , 2017, Alcohol and alcoholism.

[91]  S. Friedman,et al.  Mechanisms of hepatic stellate cell activation , 2017, Nature Reviews Gastroenterology &Hepatology.

[92]  R. Korthuis,et al.  Binge alcohol alters PNPLA3 levels in liver through epigenetic mechanism involving histone H3 acetylation. , 2017, Alcohol.

[93]  E. Gorospe,et al.  Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation. , 2017, Gastroenterology.

[94]  D. Ward,et al.  Alcohol-related changes in the intestinal microbiome influence neutrophil infiltration, inflammation and steatosis in early alcoholic hepatitis in mice , 2017, PloS one.

[95]  H. Shan,et al.  MiR‐199a‐5p suppresses tumorigenesis by targeting clathrin heavy chain in hepatocellular carcinoma , 2017, Cell biochemistry and function.

[96]  L. Ohno-Machado,et al.  Extracellular vesicles released by hepatocytes from gastric infusion model of alcoholic liver disease contain a MicroRNA barcode that can be detected in blood , 2017, Hepatology.

[97]  Yueqiu Gao,et al.  MicroRNA-223 ameliorates alcoholic liver injury by inhibiting the IL-6–p47phox–oxidative stress pathway in neutrophils , 2016, Gut.

[98]  Rajanikanth Vadigepalli,et al.  Inhibition of miR-21 rescues liver regeneration after partial hepatectomy in ethanol-fed rats. , 2016, American journal of physiology. Gastrointestinal and liver physiology.

[99]  D. Mann,et al.  Epigenetics in liver disease: from biology to therapeutics , 2016, Gut.

[100]  C. Allis,et al.  The molecular hallmarks of epigenetic control , 2016, Nature Reviews Genetics.

[101]  K. Kodys,et al.  The pro-inflammatory effects of miR-155 promote liver fibrosis and alcohol-induced steatohepatitis. , 2016, Journal of hepatology.

[102]  R. Bataller,et al.  Integrative microRNA profiling in alcoholic hepatitis reveals a role for microRNA-182 in liver injury and inflammation , 2016, Gut.

[103]  S. Mundlos,et al.  Breaking TADs: How Alterations of Chromatin Domains Result in Disease. , 2016, Trends in genetics : TIG.

[104]  C. Ha,et al.  MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression , 2016, Nature Communications.

[105]  Timothy Hardy,et al.  Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease , 2016, Gut.

[106]  G. Szabo,et al.  Alcoholic hepatitis accelerates early hepatobiliary cancer by increasing stemness and miR-122-mediated HIF-1α activation , 2016, Scientific Reports.

[107]  Cheng Huang,et al.  Silent information regulator 1 (SIRT1) ameliorates liver fibrosis via promoting activated stellate cell apoptosis and reversion. , 2015, Toxicology and applied pharmacology.

[108]  J. Mott,et al.  Role of microRNAs in Alcohol-Induced Multi-Organ Injury , 2015, Biomolecules.

[109]  K. Kodys,et al.  MicroRNA Cargo of Extracellular Vesicles from Alcohol-exposed Monocytes Signals Naive Monocytes to Differentiate into M2 Macrophages* , 2015, The Journal of Biological Chemistry.

[110]  K. Huse,et al.  A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis , 2015, Nature Genetics.

[111]  S. French,et al.  Increased DNA methylation in the livers of patients with alcoholic hepatitis. , 2015, Experimental and molecular pathology.

[112]  M. Creyghton,et al.  Inhibition of Super-Enhancer Activity in Autoinflammatory Site-Derived T Cells Reduces Disease-Associated Gene Expression. , 2015, Cell reports.

[113]  Howard Y. Chang,et al.  Single-cell chromatin accessibility reveals principles of regulatory variation , 2015, Nature.

[114]  K. Kodys,et al.  MicroRNA-155 Deficiency Attenuates Liver Steatosis and Fibrosis without Reducing Inflammation in a Mouse Model of Steatohepatitis , 2015, PloS one.

[115]  Y. Kuo,et al.  PNPLA3 Gene Polymorphism Is Associated With Predisposition to and Severity of Alcoholic Liver Disease , 2015, The American Journal of Gastroenterology.

[116]  K. Kodys,et al.  Exosomes derived from alcohol-treated hepatocytes horizontally transfer liver specific miRNA-122 and sensitize monocytes to LPS , 2015, Scientific Reports.

[117]  N. Davidson,et al.  miR-217 regulates ethanol-induced hepatic inflammation by disrupting sirtuin 1-lipin-1 signaling. , 2015, The American journal of pathology.

[118]  H. Pan,et al.  miR-26a enhances autophagy to protect against ethanol-induced acute liver injury , 2015, Journal of Molecular Medicine.

[119]  K. Kodys,et al.  Alcohol-Induced miR-27a Regulates Differentiation and M2 Macrophage Polarization of Normal Human Monocytes , 2015, The Journal of Immunology.

[120]  R. Bataller,et al.  Trends in the management and burden of alcoholic liver disease , 2015, Journal of hepatology.

[121]  J. Mathers,et al.  Differential DNA methylation of genes involved in fibrosis progression in non-alcoholic fatty liver disease and alcoholic liver disease , 2015, Clinical Epigenetics.

[122]  Pier P. Paoli,et al.  Alcohol directly stimulates epigenetic modifications in hepatic stellate cells. , 2015, Journal of hepatology.

[123]  Michael Q. Zhang,et al.  Integrative analysis of 111 reference human epigenomes , 2015, Nature.

[124]  G. Szabo,et al.  MicroRNAs in Alcoholic Liver Disease , 2015, Seminars in Liver Disease.

[125]  J. Lieb,et al.  What are super-enhancers? , 2014, Nature Genetics.

[126]  Neva C. Durand,et al.  A 3D Map of the Human Genome at Kilobase Resolution Reveals Principles of Chromatin Looping , 2014, Cell.

[127]  Hui Liu,et al.  Mallory-Denk Body (MDB) formation modulates Ufmylation expression epigenetically in alcoholic hepatitis (AH) and non-alcoholic steatohepatitis (NASH). , 2014, Experimental and molecular pathology.

[128]  Andrew L. Kung,et al.  NF-κB directs dynamic super enhancer formation in inflammation and atherogenesis. , 2014, Molecular cell.

[129]  M. Barnett,et al.  The Role of Dietary Histone Deacetylases (HDACs) Inhibitors in Health and Disease , 2014, Nutrients.

[130]  Xiuping Liu,et al.  Regulation of the Extrinsic Apoptotic Pathway by MicroRNA-21 in Alcoholic Liver Injury* , 2014, The Journal of Biological Chemistry.

[131]  K. Kodys,et al.  Micro-RNA-155 deficiency prevents alcohol-induced serum endotoxin increase and small bowel inflammation in mice. , 2014, Alcoholism, clinical and experimental research.

[132]  H. Liu,et al.  Ufmylation and FATylation pathways are downregulated in human alcoholic and nonalcoholic steatohepatitis, and mice fed DDC, where Mallory-Denk bodies (MDBs) form. , 2014, Experimental and molecular pathology.

[133]  Sarah A Heerboth,et al.  Use of Epigenetic Drugs in Disease: An Overview , 2014, Genetics & epigenetics.

[134]  Jörn Lötsch,et al.  Common non-epigenetic drugs as epigenetic modulators. , 2013, Trends in molecular medicine.

[135]  Yan Li,et al.  A high-resolution map of three-dimensional chromatin interactome in human cells , 2013, Nature.

[136]  G. Szabo,et al.  MicroRNAs in liver disease , 2013, Nature Reviews Gastroenterology &Hepatology.

[137]  G. Gonye,et al.  Chronic ethanol feeding enhances miR-21 induction during liver regeneration while inhibiting proliferation in rats. , 2012, American journal of physiology. Gastrointestinal and liver physiology.

[138]  Xiuping Liu,et al.  Epigenetic regulation of miR-34a expression in alcoholic liver injury. , 2012, The American journal of pathology.

[139]  C. McClain,et al.  Binge alcohol-induced microvesicular liver steatosis and injury are associated with down-regulation of hepatic Hdac 1, 7, 9, 10, 11 and up-regulation of Hdac 3. , 2012, Alcoholism, clinical and experimental research.

[140]  Caroline L. Wilson,et al.  Multigenerational Epigenetic Adaptation of the Hepatic Wound-Healing Response , 2012, Nature Medicine.

[141]  S. Shukla,et al.  Gene-selective histone H3 acetylation in the absence of increase in global histone acetylation in liver of rats chronically fed alcohol. , 2012, Alcohol and alcoholism.

[142]  Jesse R. Dixon,et al.  Topological Domains in Mammalian Genomes Identified by Analysis of Chromatin Interactions , 2012, Nature.

[143]  Robert-Jan Palstra,et al.  HERC2 rs12913832 modulates human pigmentation by attenuating chromatin-loop formation between a long-range enhancer and the OCA2 promoter. , 2012, Genome research.

[144]  Manolis Kellis,et al.  ChromHMM: automating chromatin-state discovery and characterization , 2012, Nature Methods.

[145]  G. Szabo,et al.  MicroRNA Signature in Alcoholic Liver Disease , 2012, International journal of hepatology.

[146]  S. Glaser,et al.  Regulation of placenta growth factor by microRNA-125b in hepatocellular cancer. , 2011, Journal of hepatology.

[147]  J. Hampe,et al.  Genetic determinants of alcoholic liver disease , 2011, Gut.

[148]  D. Franchimont,et al.  Common polymorphism in the PNPLA3/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease. , 2011, Journal of hepatology.

[149]  Yoko Ito,et al.  Maternal diet and aging alter the epigenetic control of a promoter–enhancer interaction at the Hnf4a gene in rat pancreatic islets , 2011, Proceedings of the National Academy of Sciences.

[150]  T. Luedde,et al.  Micro‐RNA profiling reveals a role for miR‐29 in human and murine liver fibrosis , 2011, Hepatology.

[151]  K. Kodys,et al.  Up-regulation of MicroRNA-155 in Macrophages Contributes to Increased Tumor Necrosis Factor α (TNFα) Production via Increased mRNA Half-life in Alcoholic Liver Disease* , 2010, The Journal of Biological Chemistry.

[152]  David A. Orlando,et al.  Mediator and Cohesin Connect Gene Expression and Chromatin Architecture , 2010, Nature.

[153]  Scott L. Friedman,et al.  Evolving challenges in hepatic fibrosis , 2010, Nature Reviews Gastroenterology &Hepatology.

[154]  J. Rehm,et al.  Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis. , 2010, Drug and alcohol review.

[155]  David E. J. Jones,et al.  Acetate, the key modulator of inflammatory responses in acute alcoholic hepatitis , 2010, Hepatology.

[156]  H. Tsukamoto,et al.  MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis. , 2010, Gastroenterology.

[157]  H. Tsukamoto,et al.  Ethanol-Induced Expression of ET-1 and ET-BR in Liver Sinusoidal Endothelial Cells and Human Endothelial Cells Involves Hypoxia-Inducible Factor-1α and MicroRNA-1991 , 2009, The Journal of Immunology.

[158]  A. Dolganiuc,et al.  MicroRNA expression profile in Lieber-DeCarli diet-induced alcoholic and methionine choline deficient diet-induced nonalcoholic steatohepatitis models in mice. , 2009, Alcoholism, clinical and experimental research.

[159]  P. Mandrekar,et al.  Signalling pathways in alcohol-induced liver inflammation. , 2009, Journal of hepatology.

[160]  Zheng Shen,et al.  Role of SIRT1 in regulation of LPS- or two ethanol metabolites-induced TNF-alpha production in cultured macrophage cell lines. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[161]  R. Bataller,et al.  Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis. , 2009, Gastroenterology.

[162]  S. French,et al.  Chronic ethanol feeding alters hepatocyte memory which is not altered by acute feeding. , 2009, Alcoholism, clinical and experimental research.

[163]  Bing Ren,et al.  Prediction of regulatory elements in mammalian genomes using chromatin signatures , 2008, BMC Bioinformatics.

[164]  G. Gores,et al.  A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis. , 2008, Gastroenterology.

[165]  Laura Pelletier,et al.  MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations , 2008, Hepatology.

[166]  Shelly C. Lu,et al.  S‐adenosylmethionine inhibits lipopolysaccharide‐induced gene expression via modulation of histone methylation , 2008, Hepatology.

[167]  Min You,et al.  Involvement of mammalian sirtuin 1 in the action of ethanol in the liver. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[168]  U. Bhadra,et al.  Distinct methylation patterns in histone H3 at Lys-4 and Lys-9 correlate with up- & down-regulation of genes by ethanol in hepatocytes. , 2007, Life sciences.

[169]  S. French,et al.  Histone acetyltransferase p300 modulates gene expression in an epigenetic manner at high blood alcohol levels. , 2007, Experimental and molecular pathology.

[170]  Nathaniel D. Heintzman,et al.  Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome , 2007, Nature Genetics.

[171]  T. Kouzarides.  Chromatin Modifications and Their Function , 2007, Cell.

[172]  A. Thorne,et al.  Regulation of myofibroblast transdifferentiation by DNA methylation and MeCP2: implications for wound healing and fibrogenesis , 2007, Cell Death and Differentiation.

[173]  P. Park,et al.  Involvement of histone acetyltransferase (HAT) in ethanol-induced acetylation of histone H3 in hepatocytes: potential mechanism for gene expression. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[174]  J. Kornhuber,et al.  Homocysteine associated genomic DNA hypermethylation in patients with chronic alcoholism , 2004, Journal of Neural Transmission.

[175]  P. Park,et al.  Acetylation of histone H3 at lysine 9 by ethanol in rat hepatocytes. , 2003, Biochemical and biophysical research communications.

[176]  M. Pucéat.  Capturing Chromosome Conformation. , 2021, Methods in molecular biology.

[177]  J. P. Bohnsack,et al.  Histone modifications, DNA methylation, and the epigenetic code of alcohol use disorder. , 2021, International review of neurobiology.

[178]  K. Kodys,et al.  MicroRNA 122, Regulated by GRLH2, Protects Livers of Mice and Patients From Ethanol-Induced Liver Disease. , 2018, Gastroenterology.

[179]  G. Szabo.  Gut-liver axis in alcoholic liver disease. , 2015, Gastroenterology.

[180]  Yanyan Zhao,et al.  MiR-214 promotes the alcohol-induced oxidative stress via down-regulation of glutathione reductase and cytochrome P450 oxidoreductase in liver cells. , 2014, Alcoholism, clinical and experimental research.

[181]  G. Gonye,et al.  Chronic ethanol feeding alters miRNA expression dynamics during liver regeneration. , 2013, Alcoholism, clinical and experimental research.

[182]  S. French,et al.  Epigenetic Events in Liver Cancer Resulting From Alcoholic Liver Disease , 2013, Alcohol research : current reviews.

[183]  R. Brůha,et al.  Alcoholic liver disease. , 2012, World journal of hepatology.

[184]  Elzo de Wit,et al.  A decade of 3C technologies: insights into nuclear organization. , 2012, Genes & development.

[185]  David Kershenobich,et al.  Variant in PNPLA3 is associated with alcoholic liver disease , 2010, Nature Genetics.

[186]  H. Tsukamoto,et al.  MicroRNA-199 and α Hypoxia-Inducible Factor-1 and Human Endothelial Cells Involves ET-BR in Liver Sinusoidal Endothelial Cells Ethanol-Induced Expression of ET-1 and , 2009 .

[187]  Pierre-Olivier Angrand,et al.  The control of histone lysine methylation in epigenetic regulation. , 2007, Biochimie.